A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another ...

Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.

This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Dr. Alexandra Sowa, an obesity medicine specialist and author of the new book “The Ozempic Revolution ... medications for Americans with Medicare and Medicaid. A shortage in injections linked to ...

Health plans are lobbying the Trump administration to scrap a proposal dating from the final days of the Biden administration ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Robert F. Kennedy — a vaccine critic, obesity-drug skeptic and processed-foods hater — has secured his spot as head of the US ...

Meanwhile, Danish health officials — where Ozempic manufacturer Novo Nordisk is based — are currently investigating potential links between semaglutide and vision loss. Though the researchers ...

Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment. Never before was there a drug that actually worked for weight loss.